Publications
Detailed Information
CpG island hypermethylation and repetitive DNA hypomethylation in premalignant lesion of extrahepatic cholangiocarcinoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Baek-hui | - |
dc.contributor.author | Cho, Nam-Yun | - |
dc.contributor.author | Shin, So Hyun | - |
dc.contributor.author | Kwon, Hyeong-Ju | - |
dc.contributor.author | Kang, Gyeong Hoon | - |
dc.contributor.author | Jang, Ja June | - |
dc.date.accessioned | 2012-05-30T07:00:52Z | - |
dc.date.available | 2012-05-30T07:00:52Z | - |
dc.date.issued | 2009-10 | - |
dc.identifier.citation | VIRCHOWS ARCHIV; Vol.455 4; 343-351 | ko_KR |
dc.identifier.issn | 0945-6317 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76622 | - |
dc.description.abstract | Biliary intraepithelial neoplasia (BilIN) is the premalignant lesion of extrahepatic cholangiocarcinoma (EHC), and there are no published data regarding epigenetic changes throughout disease progression from normal biliary epithelia to BilIN to EHC. The objective of this study was to identify the occurrence of CpG island hypermethylation and repetitive DNA hypomethylation in BilIN. A total of 50 EHCs, 31 BilINs, and 31 normal cystic duct samples were analyzed for their methylation status in seven genes and two repetitive DNA elements. The number of methylated genes increased with disease progression (normal bile duct, 0.6; BilIN, 2.0; EHC, 3.6; P<0.001). The methylation level of examined genes was significantly higher in BilIN than in normal samples (TMEFF2, HOXA1, NEUROG1, and RUNX3, P<0.05) and in EHC than in BilIN samples (TMEFF2, HOXA1, NEUROG1, RUNX3, RASSF1A, and APC, P<0.05). Long interspersed nucleotide element-1 (LINE-1) and juxtacentromeric satellite 2 (SAT2) methylation levels were markedly lower in EHC than in normal duct and BilIN samples, and BilIN samples showed a decrease of SAT2 methylation levels but no decrease of LINE-1 methylation levels compared to normal samples. These findings suggest that most of cancer-specific CpG island hypermethylation occur in the stage of BilIN and that CpG island hypermethylation seems to occur earlier than repetitive DNA element hypomethylation. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | SPRINGER | ko_KR |
dc.subject | Biliary intraepithelial neoplasia | ko_KR |
dc.subject | DNA hypomethylation | ko_KR |
dc.subject | DNA hypermethylation | ko_KR |
dc.subject | Cholangiocarcinoma | ko_KR |
dc.subject | CpG island | ko_KR |
dc.title | CpG island hypermethylation and repetitive DNA hypomethylation in premalignant lesion of extrahepatic cholangiocarcinoma | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 김백희 | - |
dc.contributor.AlternativeAuthor | 조남윤 | - |
dc.contributor.AlternativeAuthor | 신소현 | - |
dc.contributor.AlternativeAuthor | 권형주 | - |
dc.contributor.AlternativeAuthor | 장자준 | - |
dc.contributor.AlternativeAuthor | 강경훈 | - |
dc.identifier.doi | 10.1007/s00428-009-0829-4 | - |
dc.citation.journaltitle | VIRCHOWS ARCHIV | - |
dc.description.citedreference | Lee HS, 2009, CLIN CANCER RES, V15, P812, DOI 10.1158/1078-0432.CCR-08-0266 | - |
dc.description.citedreference | Cho NY, 2009, VIRCHOWS ARCH, V454, P17, DOI 10.1007/s00428-008-0706-6 | - |
dc.description.citedreference | Nakanishi Y, 2008, HUM PATHOL, V39, P1153, DOI 10.1016/j.humpath.2007.11.018 | - |
dc.description.citedreference | Ogino S, 2008, INT J CANCER, V122, P2767, DOI 10.1002/ijc.23470 | - |
dc.description.citedreference | Sasaki M, 2008, J PATHOL, V215, P175, DOI 10.1002/path.2345 | - |
dc.description.citedreference | Sato N, 2008, MODERN PATHOL, V21, P238, DOI 10.1038/modpathol.3800991 | - |
dc.description.citedreference | Brandes JC, 2007, ONCOGENE, V26, P6229, DOI 10.1038/sj.onc.1210433 | - |
dc.description.citedreference | Zen Y, 2007, MODERN PATHOL, V20, P701, DOI 10.1038/modpathol.3800788 | - |
dc.description.citedreference | Kim BH, 2007, ARCH PATHOL LAB MED, V131, P923 | - |
dc.description.citedreference | Ogino S, 2006, J MOL DIAGN, V8, P209, DOI 10.2353/jmoldx.2006.050135 | - |
dc.description.citedreference | Zen Y, 2005, PATHOL INT, V55, P180 | - |
dc.description.citedreference | Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987 | - |
dc.description.citedreference | Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137 | - |
dc.description.citedreference | Lee S, 2004, LAB INVEST, V84, P884 | - |
dc.description.citedreference | Tsuneyama K, 2004, PATHOL INT, V54, P181 | - |
dc.description.citedreference | Hake SB, 2004, BRIT J CANCER, V90, P761, DOI 10.1038/sj.bjc.6601575 | - |
dc.description.citedreference | Lee S, 2003, AM J PATHOL, V163, P1371 | - |
dc.description.citedreference | Yamanaka M, 2003, INT J CANCER, V106, P382, DOI 10.1002/ijc.11227 | - |
dc.description.citedreference | Kang GH, 2003, LAB INVEST, V83, P635, DOI 10.1097/01.LAB.0000067481.08984.3F | - |
dc.description.citedreference | Gaudet F, 2003, SCIENCE, V300, P489 | - |
dc.description.citedreference | Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816 | - |
dc.description.citedreference | GREENE FL, 2002, AJCC CANC STAGING MA | - |
dc.description.citedreference | Esteller M, 2001, CANCER RES, V61, P3225 | - |
dc.description.citedreference | Fleming KA, 2001, J HEPATOL, V34, P360 | - |
dc.description.citedreference | Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32 | - |
dc.description.citedreference | Baylin SB, 2000, TRENDS GENET, V16, P168 | - |
dc.description.citedreference | Suto T, 2000, J SURG ONCOL, V73, P158 | - |
dc.description.citedreference | AALTONEN LA, 2000, PATHOLOGY GENETICS T | - |
dc.description.citedreference | KIM J, 1998, KOREAN J PATHOL, V32, P985 | - |
dc.description.citedreference | Graff JR, 1997, J BIOL CHEM, V272, P22322 | - |
dc.description.citedreference | Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821 | - |
dc.description.citedreference | PONCHON T, 1995, GASTROINTEST ENDOSC, V42, P565 | - |
dc.description.citedreference | ISAACS WB, 1994, SEMIN ONCOL, V21, P514 | - |
dc.description.citedreference | SCARPA A, 1994, INT J CANCER, V59, P39 | - |
dc.description.citedreference | TADA M, 1990, CANCER, V66, P930 | - |
dc.description.citedreference | SUZUKI M, 1989, CANCER, V64, P658 | - |
dc.description.citedreference | FEINBERG AP, 1983, NATURE, V301, P89 | - |
dc.description.citedreference | GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P6883 | - |
dc.description.citedreference | LAITIO M, 1983, PATHOL RES PRACT, V178, P67 | - |
dc.description.tc | 4 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.